Burstein R., Jakubowski M. Almotriptan efficacy in migraine with allodynia: a critique of Schoenen et al. [editorial]. Cephalalgia 2009 ; 29: 1019-1020.
Schoenen J., De Klippel N., Giurgea S., Herroelen L., Jacquy J., Louis P., et al. Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia. Cephalalgia 2008 ; 28: 1095-1105.
Ashkenazi A., Sholtzow M., Shaw JW, Burstein R., Young WB Identifying cutaneous allodynia in chronic migraine using a practical clinical method. Cephalalgia 2007 ; 27: 111-117.
Burstein R., Yarnitsky D., Goor-Aryeh I., Ransil BJ, Bajwa ZH An association between migraine and cutaneous allodynia. Ann Neurol 2000 ; 47: 614-624.
Cady R., Martin V., Mauskop A., Rodgers A., Hustad CM, Ramsey KE, et al. Symptoms of cutaneous sensitivity pre-treatment and post-treatment: results from the rizatriptan TAME studies. Cephalalgia 2007 ; 27: 1055-1060.
Lampl C., Huber G., Haas S., Rittberger E., Diener HC Difference in triptan effect in patients with migraine and early allodynia. Cephalalgia 2008 ; 28: 1031-1038.
Goadsby PJ, Zanchin G., Geraud G., de Klippel N., Diaz-Insa S., Gobel H., et al. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)': a double-blind, placebo-controlled trial of almotriptan. Cephalalgia 2008 ; 4: 383-391.
